Paul E Firuta
CIK 1602727 · EVP, Chief Commercial Officer · last filed 2020-01-29
Paul E Firuta is an EVP, Chief Commercial Officer who has filed 10 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for ACHN, was dated Jan 29, 2020. Across all open-market trades the lifetime net is −$118.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.59M
3
10
-$118.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | EVP, Chief Commercial Officer | — | — | — | $0 | 3 | 2020-01-29 |
| QURE | Chief Commercial Officer | 93,817 | $27.57 | $2.59M | -$118.0K | 5 | 2018-01-30 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, US Comm Operations | 0 | — | — | $0 | 2 | 2015-02-24 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-29 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-01-25 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-12 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-30 | QURE | Grant (A) | +8,566 | $0 | EDGAR |
| 2018-01-03 | QURE | Sell (S) | −5,864 | -$118.0K | EDGAR |
| 2017-12-15 | QURE | Grant (A) | +56,115 | $0 | EDGAR |
| 2017-02-21 | QURE | Grant (A) | — | $0 | EDGAR |
| 2017-01-31 | QURE | Grant (A) | — | $0 | EDGAR |
| 2015-02-24 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | −1,114 | -$51.2K | EDGAR |
| 2015-02-20 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |